Last week, the U.S. Department of Health and Human Services Office of Inspector General released a report that should be required reading for every family with a loved one in a nursing home or memory care facility.
The finding: nursing homes have been inappropriately diagnosing residents with schizophrenia to mask the misuse of antipsychotic drugs and to artificially inflate their star ratings.
This isn't a fringe allegation. Medical directors made inappropriate schizophrenia diagnoses to justify prescribing antipsychotic drugs, and nursing homes used those same diagnoses to skirt Medicare safeguards intended to protect residents.
In plain terms: facilities were sedating elderly residents — many with dementia — and then falsifying diagnoses to hide it from regulators and families.
Why Schizophrenia Specifically?
CMS developed a quality measure — the percentage of residents given antipsychotic drugs — to track use in nursing homes, and this quality measure factors into a nursing home's star rating. Residents who have been diagnosed with schizophrenia are not counted toward the quality measure. As a result, nursing homes have a financial incentive to inappropriately diagnose residents with schizophrenia.
So a facility that was drugging a dementia patient to make them easier to manage could simply add a schizophrenia diagnosis to the chart — the antipsychotic use disappears from the quality metric, the star rating stays clean, and families see nothing.
A New York Times analysis of Medicare data found that one in nine nursing home patients had been diagnosed with schizophrenia, even though the rate of schizophrenia in the general population is one in 150 people — and schizophrenia diagnoses generally occur before age 40.
What Chemical Restraint Actually Looks Like
A chemical restraint is defined as any drug used to control a resident's behavior or restrict their movement that is not required to treat a medical condition. These medications are sometimes used to sedate or subdue residents, particularly those with dementia, to make caregiving easier or for discipline purposes — and this practice violates residents' rights under federal law.
When drugs are used as chemical restraints, they can cause significant harm — sedating medications can lead to falls, pressure sores, incontinence, and muscle weakness, and residents may experience a decline in physical functioning and increased dependence on staff.
The FDA states that roughly 15,000 nursing home resident deaths each year result from unnecessary antipsychotic use.
Warning Signs Families Should Watch For
If your loved one is in a nursing home or memory care facility, these are the specific signs that something may be wrong:
- Sudden unexplained drowsiness — they seem sedated, hard to wake, or unresponsive in ways that are new
- New prescriptions for antipsychotics or sedatives without a clear documented diagnosis you were told about
- A new schizophrenia diagnosis appearing in their chart — especially if they are over 65 and have no prior psychiatric history
- Loss of ability to hold a conversation, recognize family members, or respond to questions
- Increased falls or unexplained bruising — sedation impairs balance
- Staff who are evasive or dismissive when you ask about medications
If you suspect chemical restraint abuse, monitor for signs of excessive sedation and behavior changes, keep records with dates and times, and have an independent doctor review your loved one's medications and treatment plan.
Your Legal Rights — and What to Do Right Now
Under 42 CFR 483.10(e), nursing home residents have the right to be treated with respect and dignity, which includes the right to be free from chemical restraints imposed for discipline or convenience.
Chemical restraints may only be used to ensure the physical safety of residents and other individuals, consent must be given, and the resident or their representative has the right to refuse chemical restraint use even when recommended by a physician.
If you believe your loved one is being chemically restrained without proper justification:
- Request a complete medication list in writing from the facility today
- Ask specifically whether any antipsychotics are prescribed and what diagnosis they're treating
- Pull the AHCA inspection record — antipsychotic misuse often appears in deficiency citations. Search your facility at carecircle.fit/research
- Contact Florida's Long-Term Care Ombudsman at 1-888-831-0404
- File a complaint with AHCA at ahca.myflorida.com if you believe abuse is occurring
What This Means for Florida Families Statewide
We cross-reference antipsychotic use data and AHCA deficiency records for every provider in our Intelligence Scanner. Several facilities in the Pensacola area have documented citations related to medication management and resident rights. If you're evaluating a facility — or already have a loved one in one — search their profile at carecircle.fit/research before your next visit.
If you want help navigating this, call us directly at Call Now. This is exactly what we're here for.
Sources: HHS Office of Inspector General Report OEI-02-23-00201 (March 2026), Washington Post, FDA, 42 CFR 483.10(e)